Genesis Molecular AI
Unifying AI and Biotech to accelerate the discovery of new medicines
157 employees · est. 2019 · San Mateo, United States
Menten AI
Unlocking the potential of peptides macrocycles to create tomorrow's life-changing medicines with Generative AI.
19 employees · est. 2020 · San Francisco, United States
Genesis Molecular AI is the older company (2019 vs 2020); Genesis Molecular AI is the larger of the two.
Side-by-Side Comparison
| Metric | Genesis Molecular AI | Menten AI |
|---|---|---|
| Founded | ||
| Founded | 2019 older | 2020 |
| Headquarters | ||
| Headquarters | San Mateo, United States | San Francisco, United States |
| Employees | ||
| Employees | 157 larger | 19 |
| Industry | ||
| Industry | AI, Biotechnology, Information Technology | AI, Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Unknown | Seed |
| Total Funding | ||
| Total Funding | $280.13M | $4.01M |
| Funding Rounds | ||
| Funding Rounds | 5 | 3 |
| Services | ||
| Services | AI Research on Molecular Scale, AI Operating System for Molecular Design, Drug Discovery Platform | Design of Peptide Macrocycles, Generative AI Platform, Drug Discovery Optimization, Physics-Based and Quantum Simulations |
| Target Customers | ||
| Target Customers | Pharmaceutical Companies, Biotech Researchers, AI and Biotech Professionals | Top-10 Pharma Companies, Biotechnology Firms, Pharmaceutical Researchers, Drug Discovery Teams |
| Taxonomy | ||
| Taxonomy | Molecular AI, Drug Design, Generative AI, Predictive AI, Small Molecule Drug Discovery, Biotech, Generative Diffusion Models, Structure Prediction, Hit Identification, Lead Optimization, AI-enabled Discovery, Undruggable Targets, AI Platform Collaborations, Computational Chemistry, Deep Neural Networks | Generative AI, Cyclic Peptide Therapeutics, Macrocycles, Drug Discovery, Quantum Computing, Preclinical Discovery, Pharmaceutical Partnerships, Protein Drug Design, Oncology Therapeutics, Neurodegeneration Therapeutics, Enzyme Design, Oral Bioavailability, Cell Permeability, Biologics Alternatives |
| Website | ||
| Website | genesistherapeutics.ai | menten.ai |
About Genesis Molecular AI
Genesis Molecular AI, founded in 2019, stands at the intersection of AI and Biotechnology, with a mission encapsulated in its slogan: "Unifying AI and Biotech to accelerate the discovery of new medicines." Headquartered in Burlingame, CA, with strategic locations in San Diego and New York, Genesis i...
About Menten AI
Menten AI is at the forefront of leveraging Generative AI to transform the realm of biotechnology by developing cyclic peptide therapeutics. Their innovative approach targets drug areas previously unattainable by traditional small molecules and biologics. Through their proprietary platform, MAUD 1.0...
We will tell you when either one moves
BounceWatch watches Genesis Molecular AI and Menten AI for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Genesis Molecular AI and Menten AI — by email.
Frequently Asked Questions
Compare Genesis Molecular AI with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Genesis Molecular AI on 22 Sep 2026, and Menten AI on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
